Hyperbaric oxygen in exceptional acute blood-loss anemia.

Rubicon Research Repository/Manakin Repository

Hyperbaric oxygen in exceptional acute blood-loss anemia.

Show full item record


Title: Hyperbaric oxygen in exceptional acute blood-loss anemia.
Author: Hart, GB; Lennon, PA; Strauss, MB
Abstract: Intermittent exposures to hyperbaric oxygen (HBO) were used in treating 26 patients (20 females, 6 males; average age 42.5 yr +/- 21) with exceptional blood-loss anemia; 18 (69%) survived. Six of the patients who died arrived for treatment in a decerebrate or decorticate neurologic state. The admitting hematocrits (Hct) and hemoglobins (Hb) were higher in the survivors (Hct 13.6%, HB 4.7 g/dl) than in those who died (Hct 10.5%, Hb 3.8 g/dl). HBO was discontinued in the survivors when they no longer suffered from hypoxic sprue, postural hypotension, and usually when the Hct was 22% or greater and the Hb was 7 g/dl or greater. We conclude that HBO may be useful in the treatment of acute blood-loss anemia when applied early.
Description: Journal of Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc.
URI: http://archive.rubicon-foundation.org/4352
Date: 1987

Files in this item

Files Size Format View
JHM_V2N4_3.pdf 851.3Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record

Browse

My Account